Insider filing
Traded Jan 15 · filed 1 day later
Not classified as an open-market trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 17, 2025 · Filed Dec 18, 2025
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $123K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$123,303
Shares × reported transaction price
41 days after results of Nov 6, 2025, 54 days before results of Feb 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $195.36 on Dec 17, 2025, 18% above its 52-week low and 22% below its high, after a 9% rise over the previous 30 trading days
52-week range $165.15 (May 6, 2025) to $249.08 (Jan 28, 2025), 36% of the way up, from 250 adjusted closes. 30 trading days earlier: $179.04 on Nov 4, 2025. Describes the past only, not a forecast
RSI 54, 3% above its 200-day average, 3% above its 50-day average, 22% below the 52-week high, 20-day volatility 26% a year, against the S&P 500: +1 points over 1 month, +2 points over 3 months, +4 points over 6 months
From the adjusted closes up to Dec 17, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
A WARN layoff notice covering 59 workers was filed in California on October 31, 2025.
From the official state WARN list, 47 days before the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | +2.0% | −1.2% |
| 30 days | +4.5% | +0.2% | +4.3% |
| 90 days | −18.8% | −2.2% | −16.6% |
| 180 days | −25.4% | +10.9% | −36.4% |
Past results only. Not a forecast.
Insider filing
Traded Jan 15 · filed 1 day later
Not classified as an open-market trade.
Insider filing
Traded Jan 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Jan 15 · filed 1 day laterNot reported under a pre-arranged trading plan
Becton Dickinson's & Pres Med.Essntl&BioPharm sold $125K of Becton Dickinson shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.